Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  TIPS - Trends in Pharmacological Sciences

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tips.2011.07.001PMID 21893353PMCID PMC3380363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized phase II study of recombinant human endostatin plus gemcitabine/cisplatin compared with gemcitabine/cisplatin alone as first-line therapy in advanced non-small-cell lung cancer

  2012cited by this paper
• Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer

  2011cited by this paper
• Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases

  2011cited by this paper
• Apolipoprotein E and Peptide Mimetics Modulate Inflammation by Binding the SET Protein and Activating Protein Phosphatase 2A

  2011cited by this paper
• β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation

  2011cited by this paper
• β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.

  2011cited by this paper
• Nitric oxide and redox mechanisms in the immune response

  2011cited by this paper
• Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.

  2010cited by this paper
• COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer

  2010cited by this paper
• Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.

  2010cited by this paper
• Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases

  2010cited by this paper
• Src signaling in cancer invasion

  2010cited by this paper
• Early activation of the beta-catenin pathway in osteocytes is mediated by nitric oxide, phosphatidyl inositol-3 kinase/Akt, and focal adhesion kinase.

  2010cited by this paper
• Nitric oxide (NO) and cancer

  2010cited by this paper
• Nitric Oxide and Cancer: An Overview

  2010cited by this paper
• Targeting SET/I2PP2A Oncoprotein Functions as a Multi-pathway Strategy for Cancer Therapy

  2010cited by this paper
• Stem Cells , Tissue Engineering and Hematopoietic Elements Wnt /-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome

  2010cited by this paper
• Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma

  2010cited by this paper
• Targeting cancer with small molecule kinase inhibitors

  2009cited by this paper
• Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients.

  2009cited by this paper
• S-Nitrosylation at Cysteine 498 of c-Src Tyrosine Kinase Regulates Nitric Oxide-mediated Cell Invasion*

  2009cited by this paper
• Inhibition of inducible nitric oxide synthase in respiratory diseases.

  2009cited by this paper
• Induced nitric oxide synthase as a major player in the oncogenic transformation of inflamed tissue.

  2009cited by this paper
• Roles of Nox1 and other Nox isoforms in cancer development

  2009cited by this paper
• Dithiolethione Compounds Inhibit Akt Signaling in Human Breast and Lung Cancer Cells by Increasing PP2A Activity

  2009cited by this paper
• Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression.

  2009cited by this paper
• Novel Dithiolethione-Modified Nonsteroidal Anti-Inflammatory Drugs in Human Hepatoma HepG2 and Colon LS180 Cells

  2009cited by this paper
• Direct interaction between the inhibitor 2 and ceramide via sphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signaling

  2009cited by this paper
• Mechanism of PP2A-mediated IKKβ dephosphorylation: a systems biological approach

  2009cited by this paper
• Ceramide-dependent PP2A regulation of TNFalpha-induced IL-8 production in respiratory epithelial cells.

  2009cited by this paper
• Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis

  2009cited by this paper
• Protein phosphatase 2A regulatory subunits and cancer.

  2009influential reference
• Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.

  2009cited by this paper
• From promiscuity to precision: protein phosphatases get a makeover.

  2009cited by this paper
• Protein S-nitrosylation in health and disease: a current perspective.

  2009cited by this paper
• An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia

  2009cited by this paper
• Dithiolethiones for cancer chemoprevention: where do we stand?

  2008cited by this paper
• The Apolipoprotein E-mimetic Peptide COG112 Inhibits the Inflammatory Response to Citrobacter rodentium in Colonic Epithelial Cells by Preventing NF-κB Activation*

  2008cited by this paper
• Protein phosphatase 2A and rapamycin regulate the nuclear localization and activity of the transcription factor GLI3.

  2008cited by this paper
• SV40 small T antigen and PP2A phosphatase in cell transformation

  2008cited by this paper
• Principles of bioactive lipid signalling: lessons from sphingolipids

  2008cited by this paper
• Basal-like breast cancer: a critical review.

  2008cited by this paper
• The reemergence of nitric oxide and cancer.

  2008cited by this paper
• Molecular mechanisms for discrete nitric oxide levels in cancer.

  2008cited by this paper
• The chemical biology of nitric oxide: implications in cellular signaling.

  2008cited by this paper
• Multiple pathways regulated by the tumor suppressor PP2A in transformation.

  2008influential reference
• Structural mechanism of demethylation and inactivation of protein phosphatase 2A.

  2008cited by this paper
• PP2A Regulates the Pro-apoptotic Activity of FOXO1*

  2008cited by this paper
• The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.

  2008cited by this paper
• Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias

  2008cited by this paper
• Impact of apoE genotype on oxidative stress, inflammation and disease risk.

  2008cited by this paper
• Triple-negative breast cancer: therapeutic options.

  2007cited by this paper
• Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities

  2007cited by this paper
• Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

  2007cited by this paper
• Prognostic significance of iNOS in epithelial ovarian cancer.

  2007cited by this paper
• Chemosensitization of Cancer In vitro and In vivo by Nitric Oxide Signaling

  2007cited by this paper
• Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.

  2007cited by this paper
• The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

  2007cited by this paper
• Inflammation and IGF‐I activate the Akt pathway in breast cancer

  2007cited by this paper
• A specific PP2A regulatory subunit, B56γ, mediates DNA damage‐induced dephosphorylation of p53 at Thr55

  2007cited by this paper
• The Role of PP2A A Subunits in Tumor Suppression

  2007influential reference
• Hypoxia: A key regulator of angiogenesis in cancer

  2007cited by this paper
• Triple negative tumours: a critical review

  2007cited by this paper
• The Tragedy of TRIUMPH for Nitric Oxide Synthesis Inhibition in Cardiogenic Shock

  2007cited by this paper
• Rac1‐induced cell migration requires membrane recruitment of the nuclear oncogene SET

  2007cited by this paper
• CIP2A inhibits PP2A in human malignancies.

  2007cited by this paper
• Oxidative Inhibition of Protein Phosphatase 2A Activity: Role of Catalytic Subunit Disulfides

  2007cited by this paper
• Protein-tyrosine phosphatases and cancer

  2006cited by this paper
• Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.

  2006cited by this paper
• Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer

  2006cited by this paper
• Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction.

  2006cited by this paper
• The role of nitric oxide in tumour progression

  2006cited by this paper
• Protein Phosphatase 2A Regulatory Subunit B56α Associates with c-Myc and Negatively Regulates c-Myc Accumulation

  2006cited by this paper
• Structure of the protein phosphatase 2A holoenzyme.

  2006cited by this paper
• Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

  2006cited by this paper
• Involvement of PP2A in viral and cellular transformation

  2005cited by this paper
• A comprehensive pathway map of epidermal growth factor receptor signaling

  2005cited by this paper
• Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway.

  2005cited by this paper
• AKT/PKB signaling mechanisms in cancer and chemoresistance.

  2005cited by this paper
• Nrf2 as a novel molecular target for chemoprevention.

  2005cited by this paper
• Cancer-associated PP2A Aalpha subunits induce functional haploinsufficiency and tumorigenicity.

  2005cited by this paper
• Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.

  2004cited by this paper
• Polyoma Enhancer Activator 3, an Ets Transcription Factor, Mediates the Induction of Cyclooxygenase-2 by Nitric Oxide in Colorectal Cancer Cells*

  2004cited by this paper
• Identification of specific PP2A complexes involved in human cell transformation.

  2004cited by this paper
• p53: 25 years after its discovery.

  2004cited by this paper
• Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes

  2004cited by this paper
• Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide

  2004cited by this paper
• Cancer genes and the pathways they control

  2004cited by this paper
• High expression of nitric oxide synthases is a favorable prognostic sign in non‐small cell lung carcinoma

  2003cited by this paper
• Nitric oxide evoked p53-accumulation and apoptosis.

  2003cited by this paper
• Characterization of a unique aspartate-rich protein of the SET/TAF-family in the human malaria parasite, Plasmodium falciparum, which inhibits protein phosphatase 2A.

  2003cited by this paper
• Thresholds of nitric oxide-mediated toxicity in human lymphoblastoid cells.

  2003cited by this paper
• Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.

  2003cited by this paper
• The phosphoinositide 3-kinase pathway.

  2002cited by this paper
• Dephosphorylation of endothelial nitric oxide synthase contributes to the anti‐angiogenic effects of endostatin

  2002cited by this paper
• Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes.

  2002cited by this paper
• A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia.

  2002cited by this paper
• Nitric oxide-induced cellular stress and p53 activation in chronic inflammation

  2002cited by this paper
• Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aα subunit gene

  2001cited by this paper
• Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

  2001cited by this paper

• Air pollution and breast cancer risk: a Mendelian randomization study

  2025cites this paper
• Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome

  2025cites this paper
• Inducible nitric oxide synthase (iNOS): More than an inducible enzyme? Rethinking the classification of NOS isoforms

  2025cites this paper
• New thiadiazolopyrimidine-ornamented pyrazoles as prospective anticancer candidates via suppressing VEGFR-2/PI3K/Akt signaling pathway: Synthesis, characterization, in-silico, and in-vitro studies.

  2024cites this paper
• Sex-specific outcomes in cancer therapy: the central role of hormones

  2024cites this paper
• Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome

  2024cites this paper
• PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives.

  2024cites this paper
• NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer

  2024cites this paper
• Network Pharmacology Combined with Machine Learning to Reveal the Action Mechanism of Licochalcone Intervention in Liver Cancer

  2023cites this paper
• The tumor-nerve circuit in breast cancer

  2023cites this paper
• Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation

  2023cites this paper
• Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy

  2022cites this paper
• NMR Spectroscopy Study of New Imidamide Derivatives as Nitric Oxide Synthase Inhibitors.

  2022cites this paper
• Oxidative stress in breast cancer after chemotherapy

  2022cites this paper
• Identification of hub genes predicting the development of prostate cancer from benign prostate hyperplasia and analyzing their clinical value in prostate cancer by bioinformatic analysis

  2022cites this paper
• The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis

  2022cites this paper
• Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment

  2021cites this paper
• Vorinostat exhibits anticancer effects in triple-negative breast cancer cells by preventing nitric oxide-driven histone deacetylation

  2021cites this paper
• Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patients

  2021cites this paper
• Photodynamic Therapy as an Oxidative Anti-Tumor Modality: Negative Effects of Nitric Oxide on Treatment Efficacy

  2021cites this paper
• The emerging roles of nitric oxide in ferroptosis and pyroptosis of tumor cells.

  2021cites this paper
• Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO

  2021cites this paper
• Nitric Oxide and Cancer: When to Give and When to Take Away?

  2021cites this paper
• Date and Place of Birth

  2020cites this paper
• Nitric oxide-elicited resistance to anti-glioblastoma photodynamic therapy

  2020influential citation
• Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation.

  2020cites this paper
• Blocking protein phosphatase 2A with a peptide protects mice against bleomycin-induced pulmonary fibrosis

  2020cites this paper
• Nitric Oxide Inhibition of Chain Lipid Peroxidation Initiated by Photodynamic Action in Membrane Environments

  2020cites this paper
• Nitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer

  2020cites this paper
• Nitric oxide and its derivatives in the cancer battlefield.

  2019cites this paper
• Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation

  2019cites this paper
• Nitric Oxide and Cancer: To Inhibit or To Induce iNOS: That Is the Question?

  2019cites this paper
• Dephosphorylation of Girdin by PP2A inhibits breast cancer metastasis.

  2019cites this paper
• Upstream signaling events leading to elevated production of pro-survival nitric oxide in photodynamically-challenged glioblastoma cells.

  2019cites this paper
• Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism

  2019cites this paper
• Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy

  2018cites this paper
• The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

  2018cites this paper
• Prophylactic intervention of probiotics (L.acidophilus, L.rhamnosus GG) and celecoxib modulate Bax-mediated apoptosis in 1,2-dimethylhydrazine-induced experimental colon carcinogenesis

  2018cites this paper
• ANP32E induces tumorigenesis of triple‐negative breast cancer cells by upregulating E2F1

  2018cites this paper
• NO in Cancer—Carcinogenesis, Metastasis, and Therapy

  2017cites this paper
• Differentially expressed mitochondrial genes in breast cancer cells: Potential new targets for anti-cancer therapies.

  2017cites this paper
• NITRIC OXIDE-MEDIATED RESISTANCE TO PHOTODYNAMIC THERAPY IN A HUMAN BREAST TUMOR XENOGRAFT MODEL : IMPROVED OUTCOME WITH NOS 2 INHIBITORS

  2017cites this paper
• Macrophage NOS2 in Tumor Leukocytes

  2017cites this paper
• Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.

  2017cites this paper
• Design, synthesis and biochemical characterization of Fingolimod analogs for targeting PP2A

  2016cites this paper
• A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia

  2016cites this paper
• Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide

  2016cites this paper
• Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways

  2016cites this paper
• Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers.

  2016cites this paper
• Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer

  2016cites this paper
• Tension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF

  2016cites this paper
• Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options

  2016cites this paper
• What has passed is prolog: new cellular and physiological roles of G6PD

  2016cites this paper
• Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy

  2015cites this paper
• SNP Affects the Mobility of Breast Cancer Cells and the Expression of Metastasis-Related Genes

  2015cites this paper
• Signaling and stress: The redox landscape in NOS2 biology.

  2015cites this paper
• Cancer cell metabolism and the modulating effects of nitric oxide.

  2015cites this paper
• Tumour suppressor proteins in proliferating and differentiating cells

  2014cites this paper
• Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia

  2014cites this paper
• IDENTIFICATION OF NOVEL NATURAL COMPOUNDS WITH ANTI-BREAST CANCER ACTIVITIES

  2014cites this paper
• Melanoma NOS1 expression promotes dysfunctional IFN signaling.

  2014cites this paper
• Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives.

  2013cites this paper
• Anti-Metastatic and Anti-Tumor Growth Effects of Origanum majorana on Highly Metastatic Human Breast Cancer Cells: Inhibition of NFκB Signaling and Reduction of Nitric Oxide Production

  2013cites this paper
• Part III. Molecular changes induced by high nitric oxide adaptation in human breast cancer cell line BT-20 (BT-20-HNO): a switch from aerobic to anaerobic metabolism

  2013cites this paper
• Nitric oxide coordinates development of genomic instability in realization of combined effect with ionizing radiation.

  2013cites this paper
• In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness

  2013cites this paper
• Mitochondrial-associated nitric oxide synthase activity inhibits cytochrome c oxidase: implications for breast cancer.

  2013cites this paper
• Signaling and Regulation S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer

  2012cites this paper
• S-Nitrosylation of EGFR and Src Activates an Oncogenic Signaling Network in Human Basal-Like Breast Cancer

  2012cites this paper
• Pistacia chinensis inhibits NO production and upregulates HO-1 induction via PI-3K/Akt pathway in LPS stimulated macrophage cells.

  2012cites this paper
• Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer

  2012cites this paper
• Impact of Breast Cancer and Combination Chemotherapy on Oxidative Stress, Hepatic and Cardiac Markers

  2012cites this paper
• Maintenance of higher H₂O₂ levels, and its mechanism of action to induce growth in breast cancer cells: important roles of bioactive catalase and PP2A.

  2012cites this paper